Conavi Medical Corp.
CNVIF
Rank in Stocks
#33158
Conavi Medical Corp. is a medical technology firm that specializes in... Conavi Medical Corp. is a medical technology firm that specializes in developing, manufacturing, and commercializing advanced imaging solutions. These innovations are specifically designed to provide guidance during minimally invasive cardiovascular procedures. A notable product is the Novasight Hybrid System, which uniquely combines intravascular ultrasound (IVUS) and optical coherence tomography (OCT) into a single platform. This enables clinicians to obtain simultaneous and precisely co-registered images of the coronary arteries. Conavi Medical Corp. is headquartered in Toronto, Canada.
Share Price
$0.091975
Last synced: 2026-10-19
Market Cap
$7.85M
Change (1 day)
-5.26%
Change (1 year)
-88.75%
Country
CA
Trade Conavi Medical Corp. (CNVIF)
Category
Healthcare
P/B ratio for Conavi Medical Corp. (CNVIF)
P/B ratio as of October 2026 TTM: 20.06
According to Conavi Medical Corp. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 20.06. At the end of 2022 the company had a P/B ratio of -585.04.
P/B ratio history for Conavi Medical Corp. from 2007 to 2026
P/B ratio at the end of each year
| Year | P/B Ratio | Change |
|---|---|---|
| 2026 (TTM) | 20.06 | -43.70% |
| 2023 | 35.64 | -106.09% |
| 2022 | -585.04 | -1,300.42% |
| 2021 | 48.74 | -123.59% |
| 2020 | -206.59 | 531.03% |
| 2019 | -32.74 | -126.81% |
| 2018 | 122.13 | -31.89% |
| 2017 | 179.31 | -87.76% |
| 2016 | 1.47K | -130.78% |
| 2015 | -4.76K | -5,081.41% |
| 2014 | 95.57 | -87.72% |
| 2013 | 778.02 | 86.70% |
| 2012 | 416.73 | 112.61% |
| 2011 | 196.01 | 18.27% |
| 2010 | 165.73 | 55.49% |
| 2009 | 106.59 | 30.66% |
| 2008 | 81.57 | -89.18% |
| 2007 | 753.59 | 0.00% |
P/B ratio for similar companies or competitors
| Company | P/B Ratio | P/B Ratio Difference | Country |
|---|---|---|---|
| 3.5116 | -82.50% |
US
|
|
| 2.0146 | -89.96% |
IE
|
|
| 4.5025 | -77.56% |
US
|
|
| 2.5486 | -87.30% |
US
|
|
| - | - |
DE
|
